Today: 30 October 2025
Subscribe
Snowflake Stock Rockets to Record High on AI Surge – Can $300 Targets Be Next?
9 October 2025
 ·  ·  ·  ·  · 
3 mins read

Snowflake Stock Rockets to Record High on AI Surge – Can $300 Targets Be Next?

by
  • Stock Rally: SNOW hit a ~$250 high on Oct 8, 2025 (52-week high) – roughly +100% year‑over‑year [1]. Market cap is ~$80–84B at these levels.
  • Recent Earnings: In Q2 FY2026 (ended Jul ’25), Snowflake reported $1.14B revenue (+32% YoY) vs $1.09B expected and EPS $0.35 vs $0.27 expected [2]. Management raised full‑year product revenue guidance to about $4.4B (up from $4.33B) on strong demand [3].
  • Bullish Analyst Targets: Dozens of analysts have increased price targets after the beat. Notable upgrades include UBS to $310 (Buy), Piper Sandler to $285, Morgan Stanley to $272, and RBC/Needham in the $275–280 range [4] [5]. The consensus remains a Moderate Buy with median targets around $255–260 [6].
  • AI Platform Expansion: Snowflake is ramping up AI offerings – e.g. on Oct 2 it launched Cortex AI for Financial Services (agentic AI for fintech data) and integrated OpenAI/NVIDIA models into Snowflake’s platform [7] [8]. CEO Sridhar Ramaswamy emphasizes “easy, efficient, and trusted” AI (per Stratechery interview [9]) and downplays any “AI bubble,” focusing on long‑term value.
  • Competitors & Market: Key rivals include AWS Redshift, Google BigQuery and Azure Synapse in cloud data warehousing [10]. Databricks (private, ~$100B+ valuation) is a major lakehouse competitor [11] [12]. Snowflake’s unique multi‑cloud architecture and performance at scale are viewed as advantages against these peers [13].
  • Valuation: SNOW trades at premium multiples (~142× forward EPS; ~15–20× forward EV/sales) [14], well above other software names (MongoDB ~76×) and legacy tech. This rich valuation signals high growth expectations but leaves little margin for error.
  • Ownership/Insiders: Institutional investors hold the bulk of SNOW (quoted ~65–85% of shares [15] [16], led by firms like Vanguard and BlackRock). Recent insider trades: Director Michael Speiser sold $11.2M of stock on Oct 3 (briefly dragging shares ~3% lower) [17]; likewise Eagle Strategies LLC cut its stake (sold 9,563 shares on Oct 9) [18]. These did not derail the rally.

Snowflake’s shares have been on a tear through late 2025. After soaring on its strong Q2 report, SNOW traded near $247 on Oct 9 – close to its year‑high [19]. That represents triple‑digit gains versus a year ago [20]. The uptrend is driven by accelerating revenue growth and the cloud/AI hype cycle. Technically, the stock is extended (above its 50-day and 200-day moving averages around $216 and $197 [21]) but momentum remains strong. In the near term, investors will watch whether SNOW can sustain this pace or needs to consolidate around $250.

On the fundamental side, Snowflake’s Q2 results underscore robust demand. Product revenue of $1.14B (up ~32% YoY) beat expectations [22], and management lifted the full‑year outlook (to $4.4B total product revenue) [23]. Street estimates see ~24–25% annual growth for FY2026 (analysts’ consensus around $4.28B–4.40B in product revenue [24] [25]). The company is still unprofitable (net margins are negative) as it plows cash into R&D and sales, but its cash burn has been shrinking and free cash flow is turning positive. Profitability improvements or any signs of slowing growth will be key watchpoints given the high P/E valuation [26].

Analysts and experts are largely upbeat. After Q2, at least 24 analysts raised targets [27]. For example, analyst quotes highlight Snowflake’s AI-driven demand: “Investors are increasingly searching for opportunities where AI is making a real difference,” says Ben Barringer of Quilter Cheviot [28]. Janus Henderson’s Richard Clode calls Snowflake “a key beneficiary of the AI and cloud migration trend” [29]. Even Barclays noted that while the macro isn’t obviously improving, “better sales execution and new product momentum” are driving Snowflake’s results [30]. Piper Sandler praises CEO Ramaswamy’s “founder mode, always-on approach” to innovation [31]. Overall, the consensus rating is “Buy/Overweight,” though some caution about valuation (Simpy Wall St’s DCF sees the stock ~35% above fair value [32]).

On the competitive front, Snowflake’s multi-cloud strategy is often cited as a differentiator. Unlike Redshift (AWS-only) or BigQuery (GCP), Snowflake runs on AWS, Azure and Google Cloud, appealing to clients using multiple clouds. Its frictionless scaling and rich data-sharing features also set it apart. Databricks – which offers a data lakehouse and AI tools – looms large in the conversation, having just raised rounds valuing it above $100B [33]. But analysts note that Snowflake’s head start in enterprise data workloads and ecosystem partnerships (e.g. with NVIDIA on AI servers) give it an edge in many large accounts [34] [35]. In fact, Snowflake’s success feeds hyperscaler usage too, since its warehousing drives AWS/Azure/GCP spend [36].

Outlook: The outlook for SNOW is two-fold. Bull case: If AI adoption and cloud spending continue accelerating, Snowflake could extend its market dominance. New product releases (e.g. expanded Cortex AI tools) and big client wins could fuel another leg up. Some analysts see potential for SNOW into the $300+ range if execution stays flawless. Bear case: The stock is richly valued and trading at record multiples [37]. Any slowdown in growth, increased competition, or tech market rotation could trigger a pullback. Upcoming catalysts include Q3 results (due late Nov 2025) and any major AI partnership announcements. For now, investor sentiment is buoyant – but as one strategist quipped, Snowflake must continue to create value, since “the market will settle itself” over time if fundamentals don’t justify the hype (CNBC Oct 2025).

Sources: Company reports and transcripts, Reuters, ts2.tech, Investing.com, MarketBeat, Yahoo Finance, and industry analysis [38] [39] [40] [41] [42] [43] [44]. All data and quotes are up-to-date as of Oct 9, 2025.

Snowflake CEO downplays concerns of an AI bubble: 'The stock market will settle itself'
Watch this video on YouTube.

References

1. ts2.tech, 2. ts2.tech, 3. ts2.tech, 4. ts2.tech, 5. ts2.tech, 6. ts2.tech, 7. ts2.tech, 8. www.reuters.com, 9. stratechery.com, 10. ts2.tech, 11. ts2.tech, 12. www.reuters.com, 13. ts2.tech, 14. ts2.tech, 15. fintel.io, 16. www.marketbeat.com, 17. ts2.tech, 18. www.marketbeat.com, 19. ts2.tech, 20. ts2.tech, 21. www.marketbeat.com, 22. ts2.tech, 23. ts2.tech, 24. www.reuters.com, 25. www.reuters.com, 26. ts2.tech, 27. ts2.tech, 28. www.reuters.com, 29. www.reuters.com, 30. www.reuters.com, 31. www.investing.com, 32. simplywall.st, 33. www.reuters.com, 34. ts2.tech, 35. ts2.tech, 36. ts2.tech, 37. ts2.tech, 38. ts2.tech, 39. ts2.tech, 40. ts2.tech, 41. www.reuters.com, 42. www.reuters.com, 43. www.marketbeat.com, 44. fintel.io

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Bank of Canada Cuts Key Rate to 2.25% – Is This the End of Rate Cuts?
  2. UnitedHealth Stock Rallies After Bold Strategy Overhaul – Is 2026 a Turning Point?
  3. PECO Pumps $10K Grants into Parks & $12K to Heroes – Energy Stocks Rally?
  4. Alaska-Hawaiian Merger Takes Off: Single Operating Certificate and More

Stock Market Today

  • Barclays Lifts Alphabet (GOOG) Price Target to $315, Signaling Positive Outlook
    October 30, 2025, 8:32 AM EDT. Barclays analysts boosted Alphabet's price target from $250 to $315 and reiterated an overweight stance on GOOG, implying about a 14.47% upside from the prior close. Several peers joined the bullish view with TD Cowen at $280 (buy), Mizuho at $325, UBS at $255 (neutral), Baird at $275 (outperform), and Raymond James at $275 (outperform). MarketBeat shows a consensus rating of Moderate Buy and a $314.24 target for Alphabet. GOOG opened at $275.17, with a market cap around $3.33 trillion. Friday's session followed better-than-expected Q3 results: EPS of $2.87 on revenue of $102.35B; ROE ~34%, net margin 31%. 12-month high/low: $275.97/$142.66. Key metrics include P/E 29.30 and PEG 1.81.
  • Comcast tops estimates as broadband losses persist; Versant spin-out looms
    October 30, 2025, 8:22 AM EDT. Comcast beat Wall Street estimates for the third quarter, topping EPS of $1.12 (adjusted) and revenue of $31.2B, versus expectations of $1.10 and $30.7B. Yet the company posted an 8% drop in net income to $3.33B. The broadband subscriber base fell by 104,000 to about 31.4 million, marking the fourth straight quarter of declines. Comcast reiterated plans to drive broadband growth amid competition from 5G providers and moves to spin out the Versant cable-network assets. The company's mobile business added a record 414,000 customers in the quarter, lifting total mobile lines to 8.9 million, and shares rose in premarket trading.
  • Stock futures wobble as Trump-Xi truce cools rate-cut bets; Big Tech earnings in focus
    October 30, 2025, 8:20 AM EDT. US stock futures struggled after the Trump-Xi truce cooled bets on near-term rate cuts. Dow futures fell ~0.2%, with S&P 500 and Nasdaq futures near the flat line. Fed Chair Powell cautioned that a December cut is not a foregone conclusion. The Trump-Xi meeting delivered a one-year trade truce, including halved fentanyl tariffs and a pause on rare earth restrictions, while China pledged to resume buying soybeans. Eyes turn to quarterly results from Apple and Amazon after the bell, following mixed reads from Alphabet, Meta, and Microsoft. In premarket moves, Alphabet climbed about 7%, Estee Lauder rose ~5%, while Chipotle slid on a softer sales outlook.
  • Eli Lilly lifts full-year profit forecast as Zepbound demand drives stock rally; Novo Nordisk bids for Metsera
    October 30, 2025, 8:18 AM EDT. Eli Lilly lifted its full-year profit outlook after strong demand for its GLP-1 drugs Zepbound and Mounjaro. The company now guides adjusted EPS of about $23.00-$23.70, up from the prior range, as Zepbound sales surged to $3.6 billion in the quarter, beating estimates of $3.23 billion. Shares jumped roughly 7% in pre-market trading as investors digest growth and potential U.S. price discussions. CEO David Ricks credited robust demand for Lilly's Incretin portfolio. The weight-loss market remains a focus as Novo Nordisk has bid $6.5 billion for Metsera, offering $56.50 per share upfront, with milestones potentially lifting the total to $77.75 per share. Novo Nordisk stock slid after the Lilly news, reflecting shifting market dynamics.
  • Israeli tech leaders ring the NYSE opening bell ahead of NYC mayoral election
    October 30, 2025, 8:06 AM EDT. Israeli tech leaders rang the NYSE opening bell, signaling a high-profile moment for cross-Atlantic innovation and investment. The ceremony, hosted at the New York Stock Exchange, showcased prominent Israeli entrepreneurs whose ventures span cybersecurity, software and fintech. Coming as New York prepares for the NYC mayoral election, the event highlighted growing collaboration between Israeli startups and the U.S. financial scene, drawing attention from investors and market watchers. While ceremonial in nature, the bell-ringing underscored how tech ties between Tel Aviv and New York can influence funding rounds, partnerships, and market sentiment. The Jerusalem Post coverage notes the event as a symbolic bridge between two global tech hubs.
Go toTop